CVS Pharmacy Inc. settles $315 million opioid dispensing lawsuit
- Reports
- 17
- Developments
- 1
- Repetition
- 94%
New informationRepeats or wire copies
What happened
CVS Pharmacy Inc. and its subsidiaries agreed to pay $315 million to resolve a lawsuit brought by the Justice Department. The case, filed in 2024, accused the healthcare giant of unlawfully dispensing medically unnecessary prescriptions of highly addictive opioids. CVS stated that the settlement admits no wrongdoing and strongly disagreed with the claims made in the lawsuit.
Why it matters
The settlement is part of a broader effort by the federal government to hold companies accountable for contributing to the U.S. addiction and overdose crisis. This action is described by the Justice Department as a significant milestone in combating the opioid epidemic by cracking down on pharmacies.
CVS Health, Walgreens, and Rite Aid are facing opioid crisis lawsuits, and CVS recently learned it was not entitled to insurer coverage from AIG and Chubb.
Who's involved
- departmentBrought the lawsuit alleging unlawful opioid dispensing practices.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Abbott LaboratoriesSpeculative
Might face increased compliance costs and regulatory risk related to pharmaceutical manufacturing.